Multidrug resistance-associated protein (MRP) in haematological malignancies

Related Experiment Video

Updated: Oct 24, 2026

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
10:43

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein

Published on: December 3, 2010

K Nooter1, H Burger, G Stoter

  • 1Department of Medical Oncology, University Hospital Rotterdam and Rotterdam Cancer Institute, The Netherlands.

Leukemia & Lymphoma
|February 1, 1996
PubMed

Insights

Multidrug Resistance-associated Protein (MRP) is expressed in healthy blood cells but can be overexpressed in certain leukemias, potentially impacting treatment outcomes for blood cancers.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Multidrug resistance (MDR) in hematological malignancies limits treatment efficacy.
  • While P-glycoprotein is implicated, other MDR mechanisms like Multidrug Resistance-associated Protein (MRP) may also be involved.
  • Understanding MRP expression is crucial for improving treatment strategies.

Purpose of the Study:

  • To determine the expression levels of the Multidrug Resistance-associated Protein (MRP) gene and its protein product.
  • To investigate MRP expression in peripheral blood cells of healthy individuals and patients with hematological malignancies.
  • To explore the potential role of MRP in drug resistance in various blood cancers.

Main Methods:

  • Quantified MRP mRNA expression using RNase protection assay.
  • Assessed MRP glycoprotein levels via immunocytochemistry.
  • Analyzed samples from healthy volunteers and patients with leukemia, lymphoma, and multiple myeloma.

Main Results:

  • MRP was ubiquitously expressed at low levels in normal hematopoietic cells.
  • Elevated MRP mRNA and protein levels were observed in some leukemias, particularly chronic lymphocytic leukemia and prolymphocytic leukemia.
  • Acute myelocytic leukemia showed variable MRP expression, while other malignancies displayed predominantly low levels.

Conclusions:

  • Hyperexpression of MRP is a notable finding in certain leukemias.
  • Further research is required to elucidate the clinical significance of MRP in hematological malignancies.
  • MRP may represent a therapeutic target or a biomarker for drug resistance.

More Related Videos

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Related Concept Videos

Mismatch Repair01:48

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.The Mutator Protein Family Plays a Key Role in DNA Mismatch RepairThe human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...